Alnylam Pharmaceuticals (ALNY) PT Lowered to $302 at BofA Securities

February 13, 2025 12:22 PM EST
Get Alerts ALNY Hot Sheet
Price: $228.61 +1.79%

Rating Summary:
    29 Buy, 12 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 7 | Down: 16 | New: 37
Join SI Premium – FREE
BofA Securities analyst Tazeen Ahmad lowered the price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $302.00 (from $315.00) while maintaining a Buy rating.

You May Also Be Interested In





Related Categories

Analyst PT Change